Funder
This study was co-funded by the European & Developing Countries Clinical Trials Partnership, The Hague, The Netherlands and Medicines for Malaria Venture, Geneva, Switzerland.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. WHO. World Malaria Report 2017,
http://www.who.int/malaria/publications/world-malaria-report-2017/en/
(accessed 24 November May 2018).
2. WHO. Guidelines for the treatment of malaria. Third edition,
http://www.who.int/malaria/publications/atoz/9789241549127/en/
(accessed 24 November 2018).
3. Charle, P. et al. Artesunate/amodiaquine malaria treatment for Equatorial Guinea (Central Africa). Am J Trop Med Hyg 88, 1087–92 (2013).
4. Kayentao, K. et al. Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali. Malar J 8, 5 (2009).
5. Ndiaye, J. L. et al. Randomized, multicentre assessment of the efficacy and safety of ASAQ–a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Malar J 8, 125 (2009).
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献